ASLAN Pharmaceuticals to Participate in Fireside Chat at Jefferies Global Healthcare Conference
ASLAN Pharmaceuticals (Nasdaq:ASLN) announced that CEO Dr. Carl Firth will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York from June 8-10, 2022. The chat is scheduled for June 8 at 10:00 am ET. Attendees will have the opportunity for one-on-one virtual meetings with the management team. A webcast of the event will be available live and as a replay for 90 days. ASLAN is focused on developing immunology treatments, including eblasakimab for atopic dermatitis and farudodstat for autoimmune diseases.
- None.
- None.
MENLO PARK, Calif. and SINGAPORE, May 31, 2022 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that Dr Carl Firth, CEO, will participate in a fireside chat at the Jefferies Global Healthcare Conference. The conference will be held in-person in New York, NY, June 8 - 10, 2022.
Management will be available for virtual one-on-one meetings throughout the conference.
Fireside Chat details
Date: Wednesday, June 8, 2022
Time: 10:00am ET
Track: 9
Webcast link: Click here to listen in live or via replay
A replay of the presentation will be available for 90 days at the link above and in the News & Events section of ASLAN Pharmaceutical’s Investor Relations website.
Media and IR contacts
| Emma Thompson Spurwing Communications Tel: +65 6206 7350 Email: ASLAN@spurwingcomms.com | Ashley R. Robinson LifeSci Advisors, LLC Tel: +1 (617) 430-7577 Email: arr@lifesciadvisors.com |
About ASLAN Pharmaceuticals
ASLAN Pharmaceuticals (Nasdaq:ASLN) is a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients. ASLAN is currently evaluating eblasakimab, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and farudodstat (also known as ASLAN003), a potent oral inhibitor of the enzyme, DHODH, in autoimmune disease. ASLAN has a team in Menlo Park, California, and in Singapore. For additional information please visit www.aslanpharma.com or follow ASLAN on LinkedIn.
FAQ
What is the date of ASLAN Pharmaceuticals' fireside chat at the Jefferies Global Healthcare Conference?
What time is the fireside chat for ASLAN Pharmaceuticals at the Jefferies Conference?
Where will the Jefferies Global Healthcare Conference be held?
How can I access the webcast for ASLAN Pharmaceuticals' fireside chat?
What is ASLAN Pharmaceuticals currently developing?
